Sino Biopharmaceutical | 1177 - Operating Profit

Stock Price
6.25
Daily Change
0.20 3.31%
Monthly
-6.02%
Yearly
71.70%
Q1 Forecast
5.72

Sino Biopharmaceutical reported CNY5.18B in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025